Rating History for Acadia Pharmaceuticals (ACAD) by UBS

More Stocks Rated by UBS | Latest Ratings for ACAD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/13/2026 Ashwani Verma Downgrade Neutral
(Buy)		 23.00
(49.00)		 19.41
(19.12)		 -1.49% Details